The 3rd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Strasbourg, France, from 9-12 May 2016, the primary focus of the meeting being the resolution of barriers to

The Biowaivers Working Group held a face to face meeting on 2-3 November 2015 as part of the 2nd meeting of the International Generic Drug Regulators Programme (IGDRP) in Seoul, South Korea, with a

With a view to improving international cooperation and work-sharing in the assessment of ASMF/DMF for generic drugs, the members of the ASMF/DMF Working Group held a face to face meeting as part of

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Jacksonville, Florida, US, on 7 and 8 December 2015. Within the two and a half years after its establishment

The 2nd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Seoul, South Korea from 4-5 November 2015, with resolution of barriers to progress work-sharing and

The IGDRP Biowaivers working group was formed in May 2013 with the objective of establishing a common set of conditions for the granting of biowaivers as well as the expansion of the application of

The IGDRP ASMF/DMF working group was formed in May 2013 to foster international collaboration and worksharing in the area of evaluations for ASMFs/DMFs during the review of a generic drug product.

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Fukuoka on 8 and 9 June 2015.  It was the fourth meeting after its establishment in 2013.  

The International Generic Drug Regulators Programme (IGDRP) was formed following progression from its 3-year Pilot phase and continues to promote collaboration and convergence in generic drug

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Minneapolis, MN, US, on 2 and 3 June 2014. It was the second meeting of this group, following on the work